Episode
Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer
- Podcast
- Cell & Gene: The Podcast
- Published
- Nov 6, 2025
- Duration seconds
- 2042
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/advancing-hematology-and-cell-therapy-innovation-with-astrazeneca-s-aliya-omer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/advancing-hematology-and-cell-therapy-innovation-with-astrazeneca-s-aliya-omer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. Episode 115 of Cell & Gene: The Podcast features Host Erin Harris' talk with Aliya Omer, Vice President and Global Head of Hematology and Cell Therapy at AstraZeneca. Omer shares valuable insights from her rich experience leading cell therapy development across multiple top companies. She highlights the critical importance of collaboration by breaking down silos across research, manufacturing, regulatory, and commercial teams to deliv...